{"schema_version":"secwatch.filing_event.v1","accession":"0001798749-24-000033","form_type":"8-K","ticker":"JBIO","cik":"0001798749","company_name":"Jade Biosciences, Inc.","filed_at":"2024-06-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.164594+00:00","generated_at":"2026-06-01T05:39:17.651437+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"confidence":"high","headline":"Aerovate Therapeutics stockholders elect directors and ratify KPMG as auditor at 2024 annual meeting","bullets":["Stockholders elected David Grayzel, M.D. and Maha Katabi, Ph.D. as Class III directors with 24.4M and 25.9M votes for, respectively.","Ratification of KPMG LLP as independent auditor for FY 2024 was approved with 28,074,033 votes for, 511 against, 105 abstain.","The meeting was held on June 5, 2024; 28,737,381 shares were outstanding and entitled to vote as of April 12, 2024 record date."],"urls":{"canonical":"https://secwatch.observer/filing/0001798749-24-000033","json":"https://secwatch.observer/filing/0001798749-24-000033.json","markdown":"https://secwatch.observer/filing/0001798749-24-000033.md","text":"https://secwatch.observer/filing/0001798749-24-000033.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1798749/000179874924000033/0001798749-24-000033-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1798749/000179874924000033/tmb-20240605x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:39:17.651437+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}